Pregnancy outcomes among women with peptic ulcer disease

Charlotte Rosen
  • Department of Obstetrics and Gynecology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
  • Search for other articles:
  • degruyter.comGoogle Scholar
, Nicholas Czuzoj-Shulman
  • Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Quebec, Canada
  • Search for other articles:
  • degruyter.comGoogle Scholar
, Daniel S. Mishkin and Haim Arie Abenhaim
  • Corresponding author
  • Department of Obstetrics and Gynecology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada
  • Centre for Clinical Epidemiology and Community Studies, Jewish General Hospital, Montreal, Quebec, Canada
  • Email
  • Search for other articles:
  • degruyter.comGoogle Scholar

Abstract

Background

Little is known about the impact of peptic ulcer disease (PUD) on pregnancy. Our objective was to evaluate the effect of PUD on pregnancy and newborn outcomes.

Methods

A retrospective cohort study was carried out using the Healthcare Cost and Utilization Project (HCUP)-National Inpatient Sample (NIS) from the United States. The cohort consisted of all births that took place from 1999 to 2015. PUD was classified on the basis of the International Classification of Diseases-Ninth Revision (ICD-9) coding. Multivariate logistic regression was used to evaluate the adjusted effect of PUD on maternal and neonatal outcomes.

Results

Of the 13,792,544 births in this cohort, 1005 were to women with PUD (7/100,000 births). Between 1999 and 2015, prevalence of PUD in pregnancy increased from 4/100,000 to 11/100,000, respectively. Women with PUD were more commonly older and more likely to have comorbid illnesses. Women with PUD were at greater risk of preeclampsia [odds ratio (OR) 2.11, 95% confidence interval (CI) 1.67–2.66], preterm premature rupture of membranes (PPROM; OR 2.16, 95% CI 1.30–3.59), cesarean delivery (OR 1.60, 95% CI 1.40–1.82), venous thromboembolism (OR 3.77, 95% CI 2.08–6.85) and maternal death (OR 24.50, 95% CI 10.12–59.32). Births to women with PUD were at increased risk of intrauterine growth restriction (IUGR; OR 1.54, 95% CI 1.11–2.14), preterm birth (OR 1.84, 95% CI 1.54–2.21), intrauterine fetal death (OR 2.18, 95% CI 1.35–3.52) and congenital anomalies (OR 2.69, 95% CI 1.59–4.56).

Conclusion

The prevalence of PUD in pregnancy has risen over the last several years. PUD in pregnancy should be considered a high-risk condition associated with important adverse maternal and neonatal outcomes.

  • 1.

    Malfertheiner P, Chan FKL, McColl KEL. Peptic ulcer disease. Lancet 2009;374:1449–61.

  • 2.

    Gustavsson S, Kumar D, Graham DY, editors. Peptic ulcer disease, complications. Churchill Livingstone; 1992.

  • 3.

    NIS Overview.https://www.hcup-us.ahrq.gov/nisoverview.jsp.

  • 4.

    Barkun A, Leontiadis G. Systematic review of the symptom burden, quality of life impairment and costs associated with peptic ulcer disease. Am J Med 2010;123:358–66.e2.

  • 5.

    McQuaid KR. Gastrointestinal disorders. In: Papadakis MA, McPhee SJ, Rabow MW, editors. Current medical diagnosis & treatment 2018. New York, NY: McGraw-Hill Education; 2017.

  • 6.

    Abenhaim HA, Azoulay L, Holcroft CA, Bure LA, Assayag J, Benjamin A. Incidence, risk factors, and obstetrical outcomes of women with breast cancer in pregnancy. Breast J 2012;18:564–8.

  • 7.

    Aljary H, Czuzoj-Shulman N, Spence AR, Abenhaim HA. Pregnancy outcomes in women with rheumatoid arthritis: a retrospective population-based cohort study. J Matern Fetal Neonatal Med 2020;33:618–24.

  • 8.

    Hadid V, Patenaude V, Oddy L, Abenhaim HA. Sarcoidosis and pregnancy: obstetrical and neonatal outcomes in a population-based cohort of 7 million births. J Perinat Med 2015;43:201–7.

  • 9.

    Hassan N, Patenaude V, Oddy L, Abenhaim HA. Pregnancy outcomes in Marfan syndrome: a retrospective cohort study. Am J Perinatol 2015;30:123–30.

  • 10.

    Magtanong GG, Spence AR, Czuzoj-Shulman N, Abenhaim HA. Maternal and neonatal outcomes among pregnant women with fibromyalgia: a population-based study of 12 million births. J Matern Fetal Neonatal Med 2019;32:404–10.

  • 11.

    Petrangelo A, Alshehri E, Czuzoj-Shulman N, Abenhaim HA. Obstetrical, maternal and neonatal outcomes in pregnancies affected by muscular dystrophy. J Perinat Med 2018;46:791–6.

  • 12.

    Berthelsen CL. Evaluation of coding data quality of the HCUP National Inpatient Sample. Top Health Inf Manage 2000;21:10–23.

  • 13.

    Lopushinsky SR, Covarrubia KA, Rabeneck L, Austin PC, Urbach DR. Accuracy of administrative health data for the diagnosis of upper gastrointestinal diseases. Surg Endosc 2007;21:1733–7.

  • 14.

    Sung JJY, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther 2009;29:938–46.

  • 15.

    Mathews TJ, Hamilton BE. First births to older women continue to rise. NCHS data brief, no 152. Hyattsville, MD: National Center for Health Statistics; 2014.

  • 16.

    Mathews TJ, Hamilton BE. Delayed childbearing: more women are having their first child later in life. NCHS data brief, no 21. Hyattsville, MD: National Center for Health Statistics; 2009.

  • 17.

    Groenen MJM, Kuipers EJ, Hansen BE, Ouwendijk RJT. Incidence of duodenal ulcers and gastric ulcers in a Western population: back to where it started. Can J Gastroenterol 2009;23:604–8.

  • 18.

    McJunkin B, Sissoko M, Levien J, Upchurch J, Ahmed A. Dramatic decline in prevalence of Helicobacter pylori and peptic ulcer disease in an endoscopy-referral population. Am J Med 2011;124:260–4.

  • 19.

    Yuan Y, Padol IT, Hunt RH. Peptic ulcer disease today. Nat Clin Pract Gastroenterol Hepatol 2006;3:80–9.

  • 20.

    Lanciers S, Despinasse B, Mehta DI, Blecker U. Increased susceptibility to Helicobacter pylori infection in pregnancy. Infect Dis Obstet Gynecol 1999;7:195–8.

  • 21.

    Mégraud F. The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy. Therap Adv Gastroenterol 2012;5:103–9.

  • 22.

    Haeri S, Khoury J, Kovilam O, Miodovnik M. The association of intrauterine growth abnormalities in women with type 1 diabetes mellitus complicated by vasculopathy. Am J Obstet Gynecol 2008;199:278.e1–5.

  • 23.

    Kulshrestha V, Agarwal N. Maternal complications in pregnancy with diabetes. J Pak Med Assoc 2016;66(9 Suppl 1):S74–7.

  • 24.

    Castles A, Adams EK, Melvin CL, Kelsch C, Boulton ML. Effects of smoking during pregnancy. Five meta-analyses. Am J Prev Med 1999;16:208–15.

  • 25.

    Seely Ellen W, Ecker J. Chronic hypertension in pregnancy. Circulation 2014;129:1254–61.

  • 26.

    Korevaar TI, Schalekamp-Timmermans S, de Rijke YB, Visser WE, Visser W, de Muinck Keizer-Schrama SM, et al. Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study. J Clin Endocrinol Metab 2013;98:4382–90.

  • 27.

    Korevaar TIM, Derakhshan A, Taylor PN, Meima M, Chen L, Bliddal S, et al. Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta-analysis. J Am Med Assoc 2019;322:632–41.

  • 28.

    Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994;84:946–9.

  • 29.

    Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, Vannasaeng S, Nitiyanant W, Boonnamsiri V, et al. Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol (Oxf) 2001;54:365–70.

  • 30.

    Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. Br Med J 2011;342:d2616.

  • 31.

    Tingi E, Syed AA, Kyriacou A, Mastorakos G, Kyriacou A. Benign thyroid disease in pregnancy: a state of the art review. J Clin Transl Endocrinol 2016;6:37–49.

  • 32.

    Bellos I, Daskalakis G, Pergialiotis V. Helicobacter pylori infection increases the risk of developing preeclampsia: a meta-analysis of observational studies. Int J Clin Pract 2018;72:e13064.

  • 33.

    Nourollahpour Shiadeh M, Riahi SM, Adam I, Saber V, Behboodi Moghadam Z, Armon B, et al. Helicobacter pylori infection and risk of preeclampsia: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2019;32:324–31.

  • 34.

    Ali M, Muhammad E, Hameed B, Hasoobe H. The impact of Helicobacter pylori infection on iron deficiency anemia in pregnancy. Iraqi J Hematol 2017;6:60–4.

  • 35.

    Nashaat EH, Mansour GM. Helicobacter pylori and anemia with pregnancy. Arch Gynecol Obstet 2014;289:1197–202.

  • 36.

    Holmqvist ME, Neovius M, Eriksson J, Mantel A, Wallberg-Jonsson S, Jacobsson LT, et al. Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. J Am Med Assoc 2012;308:1350–6.

  • 37.

    Choung RS, Talley NJ. Epidemiology and clinical presentation of stress-related peptic damage and chronic peptic ulcer. Curr Mol Med 2008;8:253–7.

  • 38.

    Chen YH, Lin HC, Lou HY. Increased risk of low birthweight, infants small for gestational age, and preterm delivery for women with peptic ulcer. Am J Obstet Gynecol 2010;202:164.e1–8.

  • 39.

    Auger N, Le TUN, Park AL, Luo Z-C. Association between maternal comorbidity and preterm birth by severity and clinical subtype: retrospective cohort study. BMC Pregnancy Childbirth 2011;11:67.

  • 40.

    Dole N, Savitz DA, Hertz-Picciotto I, Siega-Riz AM, McMahon MJ, Buekens P. Maternal stress and preterm birth. Am J Epidemiol 2003;157:14–24.

  • 41.

    Nkansah-Amankra S, Luchok KJ, Hussey JR, Watkins K, Liu X. Effects of maternal stress on low birth weight and preterm birth outcomes across neighborhoods of South Carolina, 2000–2003. Matern Child Health J 2010;14:215–26.

  • 42.

    Eslick GD, Yan P, Xia HH, Murray H, Spurrett B, Talley NJ. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16:1677–82.

  • 43.

    Wanyama R, Kagawa MN, Opio KC, Baingana RK. Effect of maternal Helicobacter Pylori infection on birth weight in an urban community in Uganda. BMC Pregnancy Childbirth 2016;16:158.

  • 44.

    Banhidy F, Dakhlaoui A, Puho EH, Czeizel AE. Peptic ulcer disease with related drug treatment in pregnant women and congenital abnormalities in their offspring. Congenit Anom 2011;51:26–33.

  • 45.

    Brunner G, Meyer H, Athmann C. Omeprazole for peptic ulcer disease in pregnancy. Digestion 1998;59:651–4.

  • 46.

    Lam SK. Differences in peptic ulcer between East and West. Baillieres Best Pract Res Clin Gastroenterol 2000;14:41–52.

Purchase article
Get instant unlimited access to the article.
$42.00
Price including VAT
Log in
Already have access? Please log in.


Journal + Issues

The Journal of Perinatal Medicine is a truly international forum covering the entire field of perinatal medicine. It is an essential news source for all those obstetricians, neonatologists, perinatologists and allied health professionals who wish to keep abreast of progress in perinatal and related research.

Search